The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Nanobody stabilization of G protein-coupled receptor conformational states
Open accessAbstract
Remarkable progress has been made in the field of G protein-coupled receptor (GPCR) structural biology during the past four years. Several obstacles to generating diffraction quality crystals of GPCRs have been overcome by combining innovative methods ranging from protein engineering to lipid-based screens and microdiffraction technology. The initial GPCR structures represent energetically stable inactive-state conformations. However, GPCRs signal through different G protein isoforms or G protein-independent effectors upon ligand binding suggesting the existence of multiple ligand-specific active states. These active-state conformations are unstable in the absence of specific cytosolic signaling partners representing new challenges for structural biology. Camelid single chain antibody fragments (nanobodies) show promise for stabilizing active GPCR conformations and as chaperones for crystallogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The absence of the L chain means that the nanobody’s CDRs are distinct from those of antibodies in both sequence and structure, and as a result nanobodies are able to bind antibody-inaccessible epitopes in enzyme active sites, viral capsids and G protein coupled receptors [233, 234].”
From Computational approaches to therapeutic antibody design: established methods and emerging trends (2020) · cites this paper as [234]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H., Kühn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,280
Naturally occurring antibodies devoid of light chains
Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hammers, C., Songa, E. B., Bendahman, N., & Hammers, R. (1993) · Nature · doi:10.1038/363446a0 · Cited by 3,241
Crystal structure of the human β2 adrenergic G-protein-coupled receptor
Rasmussen, S. G. F., Choi, H., Rosenbaum, D. M., Kobilka, T. S., Thian, F. S., Edwards, P. C., Burghammer, M. C., Ratnala, V. R. P., Sanishvili, R., Fischetti, R. F., et al. (2007) · Nature · doi:10.1038/nature06325 · Cited by 1,935
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Wu, B., Chien, E. Y. T., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R. A., Brooun, A., Wells, P. G., Bi, F. C., et al. (2010) · Science · doi:10.1126/science.1194396 · Cited by 1,832
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola, V., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C. (2008) · Science · doi:10.1126/science.1164772 · Cited by 1,786
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,709
Léan, A. D., Stadel, J. M., & Lefkowitz, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79672-9 · Cited by 1,606
Structure of a β1-adrenergic G-protein-coupled receptor
Warne, T., Serrano‐Vega, M. J., Baker, J. G., Moukhametzianov, R., Edwards, P. C., Henderson, R. A., Leslie, A. G. W., Tate, C. G., & Schertler, G. F. X. (2008) · Nature · doi:10.1038/nature07101 · Cited by 1,377
GPCR Engineering Yields High-Resolution Structural Insights into β 2 -Adrenergic Receptor Function
Rosenbaum, D. M., Cherezov, V., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H., Yao, X.-J., Weis, W. I., Stevens, R. C., et al. (2007) · Science · doi:10.1126/science.1150609 · Cited by 1,335
Cited by
Sorted by citations
Nanobodies: natural single-domain antibodies
Muyldermans, S. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-063011-092449 · Cited by 2,304
The Molecular Basis of G Protein–Coupled Receptor Activation
Weis, W. I., & Kobilka, B. K. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-033910 · Cited by 1,227
Self-citationMicrobial and Animal Rhodopsins: Structures, Functions, and Molecular Mechanisms
Ernst, O. P., Lodowski, D. T., Elstner, M., Hegemann, P., Brown, L. S., & Kandori, H. (2013) · Chemical Reviews · doi:10.1021/cr4003769 · Cited by 1,171
Conformational biosensors reveal GPCR signalling from endosomes
Irannejad, R., Tomshine, J. C., Tomshine, J. R., Chevalier, M., Mahoney, J. P., Steyaert, J., Rasmussen, S. G. F., Sunahara, R. K., El-Samad, H., Huang, B., et al. (2013) · Nature · doi:10.1038/nature12000 · Cited by 819
Self-citationRegulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance
Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., & Christie, M. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005942 · Cited by 802
A general protocol for the generation of Nanobodies for structural biology
Pardon, E., Laeremans, T., Triest, S., Rasmussen, S. G. F., Wohlkönig, A., Ruf, A., Muyldermans, S., Hol, W. G. J., Kobilka, B. K., & Steyaert, J. (2014) · Nature Protocols · doi:10.1038/nprot.2014.039 · Cited by 802
Antibody Structure and Function: The Basis for Engineering Therapeutics
Chiu, M. L., Goulet, D. R., Teplyakov, A., & Gilliland, G. L. (2019) · Antibodies · doi:10.3390/antib8040055 · Cited by 711
Structural Biology of the Major Facilitator Superfamily Transporters
Yan, N. (2015) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-060414-033901 · Cited by 467
Structural advances for the major facilitator superfamily (MFS) transporters
Yan, N. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.01.003 · Cited by 418
Muyldermans, S. (2020) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-021419-083831 · Cited by 350
GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures
Shimada, I., Ueda, T., Kofuku, Y., Eddy, M. T., & Wüthrich, K. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.180 · Cited by 282
Nanobodies to Study G Protein–Coupled Receptor Structure and Function
Manglik, A., Kobilka, B. K., & Steyaert, J. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104710 · Cited by 270
Structural insights into the human D1 and D2 dopamine receptor signaling complexes
Zhuang, Y., Xu, P., Mao, C., Wang, L., Krumm, B., Zhou, X. E., Huang, S., Liu, H., Cheng, X., Huang, X., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.027 · Cited by 260
Subcellular Organization of GPCR Signaling
Eichel, K., & von Zastrow, M. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.11.009 · Cited by 250
Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains
Schmitz, K. R., Bagchi, A., Roovers, R. C., Henegouwen, P. M. P. V. B. E., & Ferguson, K. M. (2013) · Structure · doi:10.1016/j.str.2013.05.008 · Cited by 262
Membrane protein structure determination — The next generation
Moraes, I., Evans, G., Sánchez-Weatherby, J., Newstead, S. L., & Stewart, P. D. S. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.07.010 · Cited by 242
Comparative analysis of nanobody sequence and structure data
Mitchell, L. S., & Colwell, L. J. (2018) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25497 · Cited by 233
Functional selectivity of GPCR-directed drug action through location bias
Irannejad, R., Pessino, V., Mika, D., Huang, B., Wedegaertner, P., Conti, M., & von Zastrow, M. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2389 · Cited by 241
Computational approaches to therapeutic antibody design: established methods and emerging trends
Norman, R. A., Ambrosetti, F., Bonvin, A. M. J. J., Colwell, L. J., Kelm, S., Kumar, S., & Krawczyk, K. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz095 · Cited by 219
“The absence of the L chain means that the nanobody’s CDRs are distinct from those of antibodies in both sequence and structure, and as a result nanobodies are able to bind antibody-inaccessible epitopes in enzyme active sites, viral capsids and G protein coupled receptors [233, 234].”
BackgroundEndosomal generation of cAMP in GPCR signaling
Vilardaga, J., Jean‐Alphonse, F., & Gardella, T. J. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1611 · Cited by 219
GPCR signaling along the endocytic pathway
Irannejad, R., & von Zastrow, M. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.10.003 · Cited by 214
Alexander, E., & Leong, K. W. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02900-y · Cited by 219
Methodological advances: the unsung heroes of the GPCR structural revolution
Ghosh, E., Kumari, P., Jaiman, D., & Shukla, A. K. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3933 · Cited by 200
The Role of Ligands on the Equilibria Between Functional States of a G Protein-Coupled Receptor
Kim, T. H., Chung, K. Y., Manglik, A., Hansen, A. L., Dror, R. O., Mildorf, T. J., Shaw, D. E., Kobilka, B. K., & Prosser, R. S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja404305k · Cited by 177
Effects of endocytosis on receptor-mediated signaling
Irannejad, R., Tsvetanova, N. G., Lobingier, B. T., & von Zastrow, M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.05.005 · Cited by 178
Structural basis of epitope recognition by heavy-chain camelid antibodies
Zavrtanik, U., Lukan, J., Loris, R., Lah, J., & Hadži, S. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.09.002 · Cited by 169
Monobodies and other synthetic binding proteins for expanding protein science
Sha, F., Salzman, G., Gupta, A., & Koide, S. (2017) · Protein Science · doi:10.1002/pro.3148 · Cited by 163
SbsB structure and lattice reconstruction unveil Ca2+ triggered S-layer assembly
Baranova, E., Fronzes, R., García-Pino, A., Gerven, N. V., Papapostolou, D., Pehau‐Arnaudet, G., Pardon, E., Steyaert, J., Howorka, S., & Remaut, H. K. (2012) · Nature · doi:10.1038/nature11155 · Cited by 157
G Protein-coupled Receptor (GPCR) Signaling via Heterotrimeric G Proteins from Endosomes
Tsvetanova, N. G., Irannejad, R., & von Zastrow, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.617951 · Cited by 159
Cryo-EM structures of GPCRs coupled to Gs, Gi and Go
García‐Nafría, J., & Tate, C. G. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.02.006 · Cited by 158
Staus, D. P., Wingler, L. M., Strachan, R. T., Rasmussen, S. G. F., Pardon, E., Ahn, S., Steyaert, J., Kobilka, B. K., & Lefkowitz, R. J. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.089516 · Cited by 145
Wlodawer, A., Minor, W., Dauter, Z., & Jaskólski, M. (2013) · FEBS Journal · doi:10.1111/febs.12495 · Cited by 141
Camelid nanobodies: killing two birds with one stone
Desmyter, A., Spinelli, S., Roussel, A., & Cambillau, C. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.01.001 · Cited by 131
Polymorphic Variants of Adrenoceptors: Pharmacology, Physiology, and Role in Disease
Ahles, A., & Engelhardt, S. H. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008219 · Cited by 119
Labeling and Single-Molecule Methods To Monitor G Protein-Coupled Receptor Dynamics
Tian, H., Fürstenberg, A., & Huber, T. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00084 · Cited by 114
Fungal G-protein-coupled receptors: mediators of pathogenesis and targets for disease control
Brown, N. A., Schrevens, S., Dijck, P. V., & Goldman, G. H. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0127-5 · Cited by 120
Gardella, T. J., & Vilardaga, J. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009464 · Cited by 111
Human Adenosine A2A Receptor: Molecular Mechanism of Ligand Binding and Activation
Carpenter, B., & Lebon, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00898 · Cited by 110
Abskharon, R. N. N., Giachin, G., Wohlkönig, A., Soror, S. H. A., Pardon, E., Legname, G., & Steyaert, J. (2013) · Journal of the American Chemical Society · doi:10.1021/ja407527p · Cited by 104
From Desert to Medicine: A Review of Camel Genomics and Therapeutic Products
Ali, A., Baby, B., & Vijayan, R. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00017 · Cited by 121
Caffrey, M., Li, D., & Dukkipati, A. (2012) · Biochemistry · doi:10.1021/bi300010w · Cited by 106
Hoyer, D., & Bartfai, T. (2012) · Chemistry & Biodiversity · doi:10.1002/cbdv.201200288 · Cited by 102
Magnani, F., Serrano‐Vega, M. J., Shibata, Y., Abdul-Hussein, S., Lebon, G., Miller-Gallacher, J., Singhal, A., Strege, A., Thomas, J. A., & Tate, C. G. (2016) · Nature Protocols · doi:10.1038/nprot.2016.088 · Cited by 101
What Do Structures Tell Us About Chemokine Receptor Function and Antagonism?
Kufareva, I., Gustavsson, M., Zheng, Y., Stephens, B. S., & Handel, T. M. (2017) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-051013-022942 · Cited by 98
GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics
Mujić-Delić, A., de Wit, R. H., Verkaar, F., & Smit, M. J. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.03.003 · Cited by 105
Covalent agonists for studying G protein-coupled receptor activation
Weichert, D., Kruse, A. C., Manglik, A., Hiller, C., Zhang, C., Hübner, H., Kobilka, B. K., & Gmeiner, P. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410415111 · Cited by 97
Stoddart, L. A., Vernall, A. J., Denman, J. L., Briddon, S. J., Kellam, B., & Hill, S. J. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.07.014 · Cited by 93
Diversity and functional properties of bistable pigments
Tsukamoto, H., & Terakita, A. (2010) · Photochemical & Photobiological Sciences · doi:10.1039/c0pp00168f · Cited by 91
Scholler, P., Névoltris, D., Bundel, D. D., Bossi, S., Moreno‐Delgado, D., Rovira, X., Møller, T. C., Moustaine, D. E., Mathieu, M., Blanc, É., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01489-1 · Cited by 96
Nanobodies to study protein conformational states
Uchański, T., Pardon, E., & Steyaert, J. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.01.003 · Cited by 98
Comparing Class A GPCRs to bitter taste receptors
Pizio, A. D., Levit, A., Slutzki, M., Behrens, M., Karaman, R., & Niv, M. Y. (2015) · Methods in cell biology · doi:10.1016/bs.mcb.2015.10.005 · Cited by 95
Frei, J. N., Broadhurst, R. W., Bostock, M. J., Solt, A., Jones, A. J. Y., Gabriel, F., Tandale, A., Shrestha, B., & Nietlispach, D. (2020) · Nature Communications · doi:10.1038/s41467-020-14526-3 · Cited by 93
Conformationally selective RNA aptamers allosterically modulate the β2-adrenoceptor
Kahsai, A. W., Wisler, J. W., Lee, J., Ahn, S., Cahill, T. J., Dennison, S. M., Staus, D. P., Thomsen, A. R. B., Anasti, K. M., Pani, B., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2126 · Cited by 88
How Can Mutations Thermostabilize G-Protein-Coupled Receptors?
Vaidehi, N., Grisshammer, R., & Tate, C. G. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.09.005 · Cited by 86
Breaking the barriers in membrane protein crystallography
Kang, H. J., Lee, C., & Drew, D. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.12.018 · Cited by 91
Large-scale production and protein engineering of G protein-coupled receptors for structural studies
Milić, D., & Veprintsev, D. B. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00066 · Cited by 91
Wright, S. C., Kozielewicz, P., Kowalski-Jahn, M., Petersen, J., Bowin, C.-F., Slodkowicz, G., Martí-Solano, M., Rodriguez, D. J., Hot, B., Okashah, N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08630-2 · Cited by 87
New concepts and aids to facilitate crystallization
Bukowska, M. A., & Grütter, M. G. (2013) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2013.03.003 · Cited by 72
New Technologies for Elucidating Opioid Receptor Function
Bruchas, M. R., & Roth, B. L. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.01.001 · Cited by 73
Aminergic GPCR–Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data
Vass, M., Podlewska, S., de Esch, I. J. P., Bojarski, A. J., Leurs, R., Kooistra, A. J., & de Graaf, C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00836 · Cited by 72
Structurally Enabled Discovery of Adenosine A 2A Receptor Antagonists
Jazayeri, A., Andrews, S. P., & Marshall, F. H. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00119 · Cited by 74
Carpenter, B., & Tate, C. G. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.04.010 · Cited by 73
Tucker, D. F., Sullivan, J. T., Mattia, K.-A., Fisher, C. R., Barnes, T., Mabila, M. N., Wilf, R., Sulli, C., Pitts, M., Payne, R. J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716788115 · Cited by 73
Location Bias as Emerging Paradigm in GPCR Biology and Drug Discovery
Nezhady, M. A. M., Rivera, J. C., & Chemtob, S. (2020) · iScience · doi:10.1016/j.isci.2020.101643 · Cited by 72
de Graaf, C., Rein, C., Piwnica, D., Giordanetto, F., & Rognan, D. (2011) · ChemMedChem · doi:10.1002/cmdc.201100317 · Cited by 72
Functional selectivity of GPCR signaling in animals
Zhou, L., & Bohn, L. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.11.010 · Cited by 76
Antibodies and protein misfolding: From structural research tools to therapeutic strategies
Genst, E. D., Messer, A. C., & Dobson, C. M. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.08.016 · Cited by 70
Structural changes in the transport cycle of the mitochondrial ADP/ATP carrier
Ruprecht, J. J., & Kunji, E. R. S. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.03.029 · Cited by 67
A general approach for stabilizing nanobodies for intracellular expression
Dingus, J. G., Tang, J. C. Y., Amamoto, R., Wallick, G. K., & Cepko, C. L. (2022) · eLife · doi:10.7554/elife.68253 · Cited by 68
Ji, Y., Li, X. O., Lu, Y., Guo, P., Zhang, G., Wang, Y., Zhang, Y., Zhu, W., Pan, J., & Wang, J. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c00422 · Cited by 64
The fine art of integral membrane protein crystallisation
Birch, J., Axford, D., Foadi, J., Meyer, A., Eckhardt, A., Thielmann, Y., & Moraes, I. (2018) · Methods · doi:10.1016/j.ymeth.2018.05.014 · Cited by 63
Molecular Basis of Opioid Action: From Structures to New Leads
Manglik, A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.08.028 · Cited by 63
Use of transmission electron microscopy to identify nanocrystals of challenging protein targets
Stevenson, H. P., Makhov, A. M., Calero, M., Edwards, A. L., Zeldin, O. B., Mathews, I. I., Lin, G., Barnes, C. O., Santamaría, H., Ross, T. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400240111 · Cited by 63
Nanobodies detecting and modulating GPCRs outside in and inside out
Heukers, R., Groof, T. W. M. D., & Smit, M. J. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.01.003 · Cited by 61
Enabling STD-NMR fragment screening using stabilized native GPCR: A case study of adenosine receptor
Igonet, S., Raingeval, C., Cecon, E., Pučić‐Baković, M., Lauc, G., Cala, O., Baranowski, M., Pérez, J., Jockers, R., Krimm, I., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26113-0 · Cited by 61
Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies
Chaikuad, A., Keates, T., Vincke, C., Kaufholz, M., Zenn, M., Zimmermann, B., Gutiérrez, C., Zhang, R.-G., Hatzos-Skintges, C., Joachimiak, A., et al. (2014) · Biochemical Journal · doi:10.1042/bj20131399 · Cited by 60
Covalent Molecular Probes for Class A G Protein-Coupled Receptors: Advances and Applications
Weichert, D., & Gmeiner, P. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00070 · Cited by 59
Receptor signals come in waves
Lohse, M. J., & Calebiro, D. (2013) · Nature · doi:10.1038/nature12086 · Cited by 58
Schmidt, P. M., Thomas, L., Müller, P., Scheidt, H. A., & Huster, D. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201304928 · Cited by 53
Proof of dual-topology architecture of Fluc F− channels with monobody blockers
Stockbridge, R. B., Koide, A., Miller, C., & Koide, S. (2014) · Nature Communications · doi:10.1038/ncomms6120 · Cited by 55
G protein-coupled receptors in rheumatology
Neumann, E., Khawaja, K., & Müller‐Ladner, U. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.62 · Cited by 53
Shi, Q., Li, M., Mika, D., Fu, Q., Kim, S., Phan, J., Shen, A., Vandecasteele, G., & Xiang, Y. K. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx036 · Cited by 54
A Molecular Pharmacologist’s Guide to G Protein–Coupled Receptor Crystallography
Piscitelli, C. L., Kean, J., de Graaf, C., & Deupí, X. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099663 · Cited by 50
Gorinski, N., Kowalsman, N., Renner, U., Wirth, A., Reinartz, M. T., Seifert, R., Zeug, A., Ponimaskin, E. G., & Niv, M. Y. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.079137 · Cited by 49
Protein crystallization: Eluding the bottleneck of X-ray crystallography
Holcomb, J., Spellmon, N., Zhang, Y., Doughan, M., Li, C., & Yang, Z. (2017) · AIMS Biophysics · doi:10.3934/biophy.2017.4.557 · Cited by 49
Endomembrane-Based Signaling by GPCRs and G-Proteins
Liccardo, F., Luini, A., & Martino, R. D. (2022) · Cells · doi:10.3390/cells11030528 · Cited by 49
Advances in NMR structures of integral membrane proteins
Maslennikov, I., & Choe, S. (2013) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2013.05.002 · Cited by 47
Desmyter, A., Spinelli, S., Boutton, C., Saunders, M. J., Blanchetot, C., de Haard, H., Denecker, G., Roy, M. V., Cambillau, C., & Rommelaere, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00884 · Cited by 47
AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model
Marino, M., Zhou, L., Rincón, M. Y., Callaerts‐Vegh, Z., Verhaert, J., Wahis, J., Creemers, E., Yshii, L., Wierda, K. D. B., Saito, T., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.201809824 · Cited by 46
Biasing GPCR Signaling from Inside
Shukla, A. K. (2014) · Science Signaling · doi:10.1126/scisignal.2005021 · Cited by 46
Schlatter, D., Brack, S., Banner, D. W., Batey, S., Benz, J., Bertschinger, J., Huber, W., Joseph, C., Rufer, A. C., van der Klooster, A., et al. (2012) · mAbs · doi:10.4161/mabs.20452 · Cited by 44
Chemical Biology Methods for Investigating G Protein-Coupled Receptor Signaling
Huber, T., & Sakmar, T. P. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.009 · Cited by 42
Naganathan, S., Ye, S., Sakmar, T. P., & Huber, T. (2013) · Biochemistry · doi:10.1021/bi301292h · Cited by 42
Crystal structure of a LacY–nanobody complex in a periplasmic-open conformation
Jiang, X. J., Смирнова, И. Н., Kasho, V. N., Wu, J., Hirata, K., Ke, M., Pardon, E., Steyaert, J., Yan, N., & Kaback, H. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615414113 · Cited by 43
Identification and characterization of Nanobodies targeting the EphA4 receptor
Schoonaert, L., Rué, L., Roucourt, B., Timmers, M., Little, S., Chávez‐Gutiérrez, L., Dewilde, M., Joyce, P. I., Curnock, A. P., Weber, P., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.774141 · Cited by 38
Complex Formation between VEGFR2 and the β2-Adrenoceptor
Kilpatrick, L. E., Alcobia, D. C., White, C. W., Peach, C. J., Glenn, J. R., Zimmerman, K., Kondrashov, A. V., Pfleger, K. D. G., Ohana, R. F., Robers, M. B., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.02.014 · Cited by 39
A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation
Eden, T. W., Menzel, S., Wesolowski, J., Bergmann, P., Nissen, M., Dubberke, G., Seyfried, F., Albrecht, B., Haag, F., & Koch‐Nolte, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01989 · Cited by 38
Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity
Menzel, S., Schwarz, N., Haag, F., & Koch‐Nolte, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00266 · Cited by 38
Transmission electron microscopy for the evaluation and optimization of crystal growth
Stevenson, H. P., Lin, G., Barnes, C. O., Sutkevičiu̅tė, I., Krzysiak, T. C., Weiss, S. C., Reynolds, S. L., Wu, Y. G., Nagarajan, V., Makhov, A. M., et al. (2016) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798316001546 · Cited by 37
Metadynamics simulations of ligand binding to GPCRs
Ibrahim, P., & Clark, T. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.04.002 · Cited by 37
Metadata
- Authors
- Steyaert, J., & Kobilka, B. K.
- Affiliations
- Vrije Universiteit Brussel (BE)
- Stanford Medicine (US)
- Corresponding author
- Steyaert, Jan
- Venue
- Current Opinion in Structural Biology
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 21
- Issue
- 4
- Pages
- 567-572
- ISSN
- 0959-440X (ISSN-L)
- PMC
- PMC3166880
- OpenAlex
- W1975641514
- Cited by
- 234
- References
- 50
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 10 · 2023: 6 · 2022: 11 · 2021: 6 · 2020: 14 · 2019: 21 · 2018: 17 · 2017: 21 · 2016: 15 · 2015: 18 · 2014: 30 · 2013: 36 · 2012: 9
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Current Opinion in Structural Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (GM083118, R01GM083118)
- National Institute of Neurological Disorders and Stroke (NS-028471, R01NS028471, R37NS028471)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- G protein-coupled receptors, nanobodies, G protein-independent signaling, crystallogenesis, molecular chaperones
- MeSH terms
- Animals, Humans, Immunoglobulin Fragments, Protein Conformation, Crystallography, X-Ray, Receptors, G-Protein-Coupled, Protein Stability, Single-Chain Antibodies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review